Frontline Ltd. (FRO)
NYSE: FRO
· Real-Time Price · USD
18.98
-0.57 (-2.92%)
At close: Jun 20, 2025, 3:59 PM
18.98
-0.03%
After-hours: Jun 20, 2025, 05:30 PM EDT
-2.92% (1D)
Bid | 18.98 |
Market Cap | 4.23B |
Revenue (ttm) | 1.9B |
Net Income (ttm) | 348.05M |
EPS (ttm) | 1.57 |
PE Ratio (ttm) | 12.09 |
Forward PE | 6.41 |
Analyst | Buy |
Ask | 19 |
Volume | 2,555,376 |
Avg. Volume (20D) | 3,020,296 |
Open | 19.33 |
Previous Close | 19.55 |
Day's Range | 18.81 - 19.41 |
52-Week Range | 12.40 - 26.53 |
Beta | 0.31 |
Analyst Forecast
According to 0 analyst ratings, the average rating for FRO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Frontline Ltd. is scheduled to release its earnings on Aug 29, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
5 days ago
+4.66%
Shares of energy stocks are trading higher as oil ...
Unlock content with
Pro Subscription
1 week ago
+7.46%
Shares of energy stocks are trading higher following Israel's strikes on Iran, which have raised oil prices amid potential disruptions in production.

4 days ago · accessnewswire.com
Mipletamig Demonstrates Compelling Clinical Activity in Frontline AML85% remission rate observed in evaluable frontline AML patients Mipletamig combination enables rare pathway to transplant in a previously ineligible unfit patient No dose-limiting toxicities observed ...

4 weeks ago · seekingalpha.com
Frontline plc (FRO) Q1 2025 Earnings Call TranscriptFrontline plc (FRO) Q1 2025 Earnings Call Transcript